Drug Enforcement Administration (DEA) Controlled Substances Module and Handbook 2022: Guide to Manufacturing, Storing, Securing, Shipping, Distributing, Importing, Exporting and Disposal – ResearchAndMarkets.com

Drug Enforcement Administration (DEA) Controlled Substances Module and Handbook 2022: Guide to Manufacturing, Storing, Securing, Shipping, Distributing, Importing, Exporting and Disposal - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Controlled Substances Module and Handbook” directory has been added to ResearchAndMarkets.com’s offering.

You need easy-to-understand text that clarifies what each regulation under the Controlled Substances Act requires. The Controlled Substances Handbook describes in plain English detailed Drug Enforcement Administration (DEA) requirements for manufacturing, storing, securing, shipping, distributing, importing, exporting and disposing of controlled substances as well as evolving requirements for electronic prescribing and online pharmacies.

Key Topics Covered:

Introduction

Glossary A-Z

Definitions

Registration of Manufacturers, Distributors & Dispensers of Controlled Substances

Labeling & Packaging Requirements

Quotas

Records & Reports of Registrants

Orders for Schedules I and II

Prescriptions

Miscellaneous

Schedules of Controlled Substances

Registration for List I Chemicals

Records and Reports of Listed Chemicals

Electronic Orders and Prescriptions

Importation and Exportation

Import/Export of Listed Chemicals

Retail Sale of Scheduled Listed Products

Importation, Production Quotas for List I Chemicals

Administrative Functions, Practices, Procedures

Disposal

Manufacture of Marihuana for Research Purposes

DEA Mailing Addresses

For more information about this directory visit https://www.researchandmarkets.com/r/pojjvh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.